Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Changlian Wang"'
Autor:
Chen Liu, Suying Yan, Yuqin Wang, Jinwei Wang, Xiujuan Fu, Hongtao Song, Rongsheng Tong, Mei Dong, Weihong Ge, Jiawei Wang, Hui Yang, Changlian Wang, Peiyuan Xia, Limei Zhao, Sijing Shen, Juan Xie, Yangui Xu, Peizhi Ma, Hongjian Li, Shegui Lu, Yufeng Ding, Ling Jiang, Yang Lin, Maoyi Wang, Feng Qiu, Wanyu Feng, Li Yang
Publikováno v:
Kidney Diseases, Pp 1-13 (2020)
Introduction: Drug-induced acute kidney injury (D-AKI) is one of the important types of AKI. The incidence of D-AKI in China has rarely been studied. Objective: This study aims to explore the disease burden, related drugs, and risk factors of D-AKI.
Externí odkaz:
https://doaj.org/article/ecfe36f632c245a7a256ab7e052384b4
Autor:
Zheng Jiao, Changlian Wang, Jiashan Dong, Cuihong Lin, Wei-Wei Lin, Dayong Zeng, Yi-wei Liu, Pinfang Huang, Weiwei Zheng, Rongfang Lin
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 128:482-492
Azathioprine is a first-line drug used to maintain the remission of inflammatory bowel disease (IBD). As a prodrug, azathioprine is metabolised to produce active 6-thioguanine nucleotides (6-TGN). There are large individual variations in the pharmaco
Publikováno v:
Journal of Chinese Pharmaceutical Sciences. 29:542-553
Autor:
Peiyuan Xia, Maoyi Wang, Yang Lin, Rongsheng Tong, Chen Liu, Weihong Ge, Peizhi Ma, Suying Yan, Juan Xie, Wanyu Feng, Yuqin Wang, Xiujuan Fu, Limei Zhao, Ling Jiang, Hongtao Song, Changlian Wang, Mei Dong, Li Yang, Shegui Lu, Yangui Xu, Sijing Shen, Hongjian Li, Feng Qiu, Hui Yang, Yufeng Ding, Jiawei Wang, Jinwei Wang
Publikováno v:
Kidney Diseases, Pp 1-13 (2020)
Kidney Dis (Basel)
Kidney Dis (Basel)
Introduction: Drug-induced acute kidney injury (D-AKI) is one of the important types of AKI. The incidence of D-AKI in China has rarely been studied. Objective: This study aims to explore the disease burden, related drugs, and risk factors of D-AKI.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9f17e699c75e11868f38f8839be3d4
https://www.karger.com/Article/FullText/510455
https://www.karger.com/Article/FullText/510455
Autor:
Dian Gu, Changlian Wang, Meiyue Li, Pinfang Huang, Shaohong Luo, Shen Lin, Xiongwei Xu, Xin Rao, Xiuhua Weng
Publikováno v:
Oncologist
Background The latest published CASPIAN trial demonstrated that adding durvalumab to etoposide and platinum (EP) improved survival dramatically for patients with extensive-stage small cell lung cancer (ES-SCLC). Considering the high cost of durvaluma
Autor:
Qiao Wang1,2, Xinjiao Luo1,2, Changlian Wang1,3 chjwang@hfut.edu.cn, Yi Liu4, Penggan Zhou5, Bing Li5
Publikováno v:
Process Safety & Environmental Protection: Transactions of the Institution of Chemical Engineers Part B. Feb2022, Vol. 158 Issue Part B, p331-339. 9p.
Autor:
Juan Xie, Ling Jiang, Wanyu Feng, Suying Yan, Yufeng Ding, Li Yang, Shegui Lu, Weihong Ge, Hui Yang, Hongtao Song, Peiyuan Xia, Sijing Shen, Yangui Xu, Changlian Wang, Mei Dong, Limei Zhao, Rongsheng Tong, Hongjian Li, Xiujuan Fu, Yang Lin, Chen Liu, Feng Qiu, Jiawei Wang, Jinwei Wang, Peizhi Ma, Maoyi Wang
Publikováno v:
SSRN Electronic Journal.
Background: Acute kidney injury (AKI) is a severe kidney disease. Drug-induced AKI (D-AKI) is one type of AKI, which is difficult to be diagnosed. The incidence of D-AKI in China has rarely been studied. This study aims to explore the disease burden,
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 150
In this study, we constructed a sandwich-type biosensor to identify six common types of mutations in exon 19 of the epidermal growth factor receptor (EGFR) gene, and tested them using tissue samples from patients with non-small cell lung carcinomas.
Publikováno v:
Journal of Chinese Pharmaceutical Sciences; Aug2020, Vol. 29 Issue 8, p542-553, 12p
Autor:
Jin Zhang, Weiwei Lin, Wei Wu, Xianzhong Guo, Pinfang Huang, Xinhua Lin, Zheng Jiao, Changlian Wang
Publikováno v:
Journal of Chinese Pharmaceutical Sciences; Apr2020, Vol. 29 Issue 4, p260-271, 12p